Vascular access in haemodialysis patients: A modifiable risk factor for bacteraemia and death

QJM: An International Journal of Medicine

Volumn 100, Issue 7, 2007, Pages 415-422

  Thomson, Peter C ^a   Stirling, C M ^a   Geddes, C C ^b   Morris, S T ^a   Mactier, R A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS SHUNT; ARTICLE; BACTEREMIA; BACTERIAL TRANSMISSION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VASCULAR ACCESS;

EID: 34447318860     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm040     Document Type: Article

References (25)

1. UK Renal Registry. The Seventh Annual Report. 2004.
2. Bloembergen BE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Renal Replac Ther 1996; 3 201-7.
3. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: A critical survey. Kidney Int 1993; 43(Suppl.) S135-42.
4. Powe NR, Jaar B, Furth SL. Septicaemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 1999; 55:1081-90.
5. Mickely V. Central venous catheters: Many questions, few answers. Nephrol Dial Transplant 2002; 17:1368-73.
6. Saad TF. Bacteremia associated with tunnelled-cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34:1114-24.
7. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicaemia, access and cardiovascular disease in dialysis patients: The URDS Wave 2 Study. Kidney Int 2005; 68:311-18.
8. Weijmer MC, Vervloet MG, Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19:670-7.
9. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H. Prevention of tunnelled haemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomised controlled study. J Am Soc Nephrol 2002; 13:2133-9.
10. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunnelled haemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66:801-5.
11. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine containing lock solution. Nephrol Dial Transplant 2004; 19:1546-51.
12. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK. Prevention of uncuffed haemodialysis catheter-related bacteraemia using an antibiotic lock technique: A prospective, randomised clinical trial. Kidney Int 2006; 69:161-4.
13. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicentre prospective study of risk factors for bacteraemia in chronic haemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.
14. Nissenson AR, Dylan ML, Griffiths RI, Yu H-T, Dean BB, Danese MD, Dubois RW. Clinical and economic outcomes of staphylococcus aureus septicaemia in ESRD patients receiving haemodialysis. Am J Kidney Dis 2005; 46:301-8.
15. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller L, Schluman KA, Corey GR, Fowler VG. Clinical outcomes and costs due to staphylococcus aureus bacteraemia among patients receiving longterm hemodialysis. Infect Control Hosp Epidemiol 2005; 26:534-9.
16. Wylie DH, Crook DW, Peto TEA. Mortality after staphylococcus aureus bacteraemia in two acute hospitals in Oxfordshire, 1997-2003. Br Med J 2006; 333:281-4.
17. George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: Prospective study. Br Med J 2006; 332:1435-9.
18. Abbott KC, Agodoa LY. Aetiology of bacterial septicaemia in chronic dialysis patients in the United States. Clin Nephrol 2001; 56 124-31.
19. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicaemia in the United States Dialysis Population, 1991 to 1999. J Am Soc Nephrol 2004; 15:1038-45.
20. Neilson J, Kolmos H, Espersen F. Staphylococcus aureus bacteraemia among patients undergoing dialysis - focus on dialysis catheter-related cases. Nephrol Dial Transplant 1998; 13:139-45.
21. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteraemia and outcome of attempted salvage in patients undergoing haemodialysis. Ann Intern Med 1997; 127 275.
22. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS. Atherosclerotic cardiovascular disease risks in chronic haemodialysis patients. Kidney Int 2000; 55:648-58.
23. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-18.
24. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50.
25. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-43.